Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)

Tasly Pharmaceutical Group Revenue

Tasly Pharmaceutical Group had revenue of 2.32B CNY in the quarter ending June 30, 2024, with 0.68% growth. This brings the company's revenue in the last twelve months to 8.65B, down -3.80% year-over-year. In the year 2023, Tasly Pharmaceutical Group had annual revenue of 8.67B with 0.42% growth.

• Revenue (ttm): 8.65B
• Revenue Growth: -3.80%
• P/S Ratio: 2.71
• Revenue / Employee: 938.28K
• Employees: 9,223
• Market Cap: 23.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.67B	36.58M	0.42%
Dec 31, 2022	8.64B	685.47M	8.62%
Dec 31, 2021	7.95B	-5.62B	-41.43%
Dec 31, 2020	13.58B	-5.42B	-28.54%
Dec 31, 2019	19.00B	1.01B	5.61%